RA0384

antibody from Oursmab

Targeting: IL33 C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0384

Provider

Oursmab

Product name

Torudokimab (Biosimilar Reference Antibody) (IL33)

Antibody type

Monoclonal

Description

Torudokimab is a humanized monoclonal antibody targeting interleukin-33 (IL-33), a cytokine released by epithelial and endothelial cells upon tissue damage. It binds to and neutralizes IL-33, blocking its interaction with the ST2 receptor to suppress type 2 inflammatory responses. It is being developed for the treatment of allergic and eosinophilic diseases, such as severe asthma and atopic dermatitis.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Torudokimab (Biosimilar Reference Antibody) (IL33)-RA0384-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Torudokimab (Biosimilar Reference Antibody) (IL33)-RA0384 in a linear range of 15.63¨C125 ng/mL.